Vanda Pharmaceuticals, Inc. (VNDA) Misses Q1 Views
Tweet Send to a FriendGet Alerts VNDA Hot Sheet
Price: $7.09 --0%
Revenue Growth %: -0.5%
Financial Fact:
Licensing agreement: 6.61M
Today's EPS Names:
DSX, REDF, REX, More
Revenue Growth %: -0.5%
Financial Fact:
Licensing agreement: 6.61M
Today's EPS Names:
DSX, REDF, REX, More
Trade VNDA Now!
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q1 EPS of ($0.28), $0.12 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.14 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
- LTX-Credence Corp (LTXC) Misses Q3 EPS by 2c; Issues Weak Q4 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
